DAHUA-TECHNOLOGY
10.8.2021 15:47:09 CEST | Business Wire | Press release
Dahua Technology, a world leading video-centric smart IoT solution and service provider, has recently released its upgraded Full-color 2.0 Network Cameras that offer brand new functions – including Dual-lens, 4K Color Image, Vari-focal Lens, and AI Features – that can significantly optimize surveillance monitoring and greatly benefit end users in terms of clear and colorful image output.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210810005584/en/
Dual-lens Camera
The upgraded Full-color 2.0 offers dual-lens cameras with large F1.0 aperture, and Dual Light Fusion technology that collects visible color details and lightness information using separate lenses. Equipped with dual CMOS (1/1.8” and 1/2.8”), these cameras provide 36% increase in brightness and 14 times increase in s/n ratio. With pixel-level frame-by-frame mapping, they present high image definition and vivid colors even when the supplementary white light is off, thus reducing light pollution and attraction of insects. Also, its high precision AA (Active Alignment) process ensures that the lenses and sensors are all precisely aligned, allowing it to capture clear color images.
4K Color Image
The 4K network cameras of Full-color 2.0 are equipped with 1/1.2” image sensor. Compared with conventional 8MP camera, this image sensor significantly increases the pixel size by 110%, allowing it to capture real-time 4K color images even under low-light condition. These cameras also boast 42% increase in brightness, and 400% increase in S/N Ratio, providing a clear and high-quality image of the monitored scene.
Vari-focal Lens
The Full-color 2.0 cameras with vari-focal lens offer approx. 5x optical zoom and auto focus function that can maintain clear details even after zooming in. It solves the difficulty in capturing vivid color details of targets during night time or in environments with low illumination, which is a common pain point when using traditional IR vari-focal cameras. It covers narrow indoor spaces and wide outdoor scenarios, which can help ease operation and save time and labor costs.
AI Features
The upgraded Full-color 2.0 network cameras can work with Dahua 5-I/L series NVR, which enables color search for human and vehicle targets (person’s clothes and car exterior) and allows extraction of relevant video footages. It also offers AI Schedule that allows users to set different AI functions according to the time schedule.
By releasing its upgraded Full-color 2.0 Network Cameras, Dahua Technology delivers another artillery of new technologies that can enhance conventional monitoring and meet the various requirements of its customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210810005584/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Angel Aligner Unveils Six Innovations for 202711.11.2026 17:23:00 CET | Press release
Angel Elevates the Orthodontic Specialty by Focusing on Complex-Case Solutions Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATMsystem for next generation growth guidance for young patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110338654/en/ Unveiling Angel's 2027 Innovations. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver said: “In over 4 decades, I’ve never had a parent say I’d be happy if you ensure that my child’s treatment results are average.” Angel is committed to elevating the orthodontic specialty well above the average, especially as more competition and harder referral cases demand outstanding results. Bind
Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation11.11.2026 15:58:00 CET | Press release
Partnerships span drug discovery, clinical research, preventive and reproductive health Launch of an AI Clinician Framework and a Trusted Research Environment for health and genomic data Four whitepapers address genomics, therapeutics, fertility and wearable technologies New programmes support health innovators and entrepreneurs More than 17,300 visitors from 85 countries, with 130 speakers across 45 sessions Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 concluded with agreements and initiatives spanning drug discovery, clinical research, preventive and reproductive health, alongside research and entrepreneurship programmes that will sustain collaboration beyond the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111545964/en/ The Summit is the annual flagship gath
De' Longhi Group: Record Results for the Quarter, With Revenue Growing by 7.7% and Net Profit Pertaining to the Group Progressing Significantly by 19%11.11.2026 15:58:00 CET | Press release
The Board of Directors of De' Longhi S.p.A. approved the consolidated results1 for the nine months of 2026. In the nine months the Group achieved: revenues for € 2,621.3 million, up by 6.5% with respect to 2025 (+7.7% at constant currency); an adjusted2 Ebitda of € 455.2 million, equal to 17.4% on revenues (vs. 15.8% with respect to last year); a net income pertaining to the Group equal to € 225.8 million (+20.4% with respect to last year); a positive net financial position equal to € 606.0 million. CEO Fabio de' Longhi commented: “The Group delivered its thirteenth consecutive quarter of organic revenue growth, underscoring our proven ability to capitalize on industry opportunities and respond promptly to market evolution, while ensuring consistent performance across both divisions. The professional business recorded a strong acceleration, spanning all geographies and brands, with revenues growth exceeding 35% for both the quarter and the nine-month period, this against an already par
Starr Chile Assigned A Rating from AM Best11.11.2026 14:30:00 CET | Press release
Starr, a global insurance and investment organization, today announced that the global credit rating agency AM Best has assigned Starr International Seguros Generales S.A. (Starr Chile) a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent). The outlook for both credit ratings is positive. The rating reflects Starr’s strong balance sheet and Starr Chile’s successful implementation of Starr’s business model. AM Best also cited Starr’s operating performance, a favorable business profile and enterprise risk management as key factors supporting the positive rating. “This strong rating is another important endorsement of Starr’s business model as we continue to build our presence in Latin America,” said Jeff Greenberg, chairman and co-CEO of Starr. “It reflects the financial strength, underwriting discipline and experienced teams that underpin our business around the world, reinforcing the confidence brokers and clients can place in Starr.” Starr
Epinal, Inc. Emerges from Stealth with First-of-Its-Kind Breakthrough Semiconductor Electrochemical Biosensor (SEB) for Detection of Narcotics and Disease Biomarkers in Human Breath in Minutes11.11.2026 14:22:00 CET | Press release
Southern California-Based Company has developed a disruptive biosensor for integration into next-generation screening and diagnostic devices Epinal, Inc., after over six years of under-the-radar development, has officially emerged from stealth mode, introducing a breakthrough Semiconductor Electrochemical Biosensor (SEB) designed to detect narcotics and disease biomarkers directly from human breath in minutes. By combining advanced semiconductors, electrochemical sensing, tailored protein engineering, and artificial intelligence, Epinal has addressed the historical sensitivity, selectivity, scaling, stability, and signal-to-noise limitations that have long bottlenecked biosensors. Epinal’s Semiconductor Electrochemical Biosensor (SEB) will be integrated into the next generation of low cost, disposable, single-use breathalyzer cartridges where the integrity of test results is of utmost importance. In the case of narcotic detection, a rapid, non-invasive, and objective result changes an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
